Publications of Patterns of Care Data

2019

Schlichting JA, Pagedar NA, Chioreso C, Lynch CF, Charlton ME. Treatment trends in head and neck cancer: Surveillance, Epidemiology, and End Results (SEER) Patterns of Care analysis. Cancer Causes Control. 2019 Jul;30(7):721-732. [View Abstract]External Web Site Policy

Mobley EM, Charlton ME, Ward MM, Lynch CF. Nonmetropolitan residence and other factors affecting clinical trial enrollment for adolescents and young adults with cancer in a US population-based study. Cancer. 2019 Mar 22. [Epub ahead of print] [View Abstract]External Web Site Policy

Parsons HM, Penn DC, Li Q, Cress RD, Pollock BH, Malogolowkin MH, Wun T, Keegan THM. Increased clinical trial enrollment among adolescent and young adult cancer patients between 2006 and 2012-2013 in the United States. Pediatr Blood Cancer. 2019 Jan;66(1):e27426. [View Abstract]External Web Site Policy

Muffly L, Li Q, Alvarez E, Kahn J, Winestone L, Cress R, Penn DC, Keegan THM. Hematopoietic Cell Transplantation in Young Adult Acute Lymphoblastic Leukemia: A United States Population-Level Analysis. J Adolesc Young Adult Oncol. 2019 Jun;8(3):254-261. [View Abstract]External Web Site Policy

Seymour EK, Ruterbusch JJ, Beebe-Dimmer JL, Schiffer CA. Real-world testing and treatment patterns in chronic lymphocytic leukemia: A SEER patterns of care analysis. Cancer. 2019 Jan 1;125(1):135-143. [View Abstract]External Web Site Policy

2018

Enewold L, Penn DC, Stevens JL, Harlan LC. Black/white differences in treatment and survival among women with stage IIIB-IV breast cancer at diagnosis: a US population-based study. Cancer Causes Control. 2018 Jul;29(7):657-665. [View Abstract]External Web Site Policy

Penn DC, Baker M, Geiger AM, Harlan LC. Treatment and Survival Disparities in the National Cancer Institute's Patterns of Care Study (1987-2017). Cancer Invest. 2018;36(6):319-329. [View Abstract]External Web Site Policy

2017

Enewold L, Sharon E, Thomas A. Patterns of care and survival among patients with malignant mesothelioma in the United States. Lung Cancer. 2017 Oct;112:102-108. [View Abstract]External Web Site Policy

Pagedar NA, Chioreso C, Schlichting JA, Lynch CF, Charlton ME. Treatment selection in oropharyngeal cancer: a surveillance, epidemiology, and end results (SEER) patterns of care analysis. Cancer Causes Control. 2017 Oct;28(10):1085-1093. [View Abstract]External Web Site Policy

Murphy CC, Sanoff HK, Stitzenberg KB, Baron JA, Lund JL, Sandler RS. Patterns of Sociodemographic and Clinicopathologic Characteristics of Stages II and III Colorectal Cancer Patients by Age: Examining Potential Mechanisms of Young-Onset Disease. J Cancer Epidemiol. 2017;2017:4024580. [View Abstract]External Web Site Policy

Kaniski F, Enewold L, Thomas A, Malik S, Stevens JL, Harlan LC. Temporal patterns of care and outcomes of non-small cell lung cancer patients in the United States diagnosed in 1996, 2005, and 2010. Lung Cancer. 2017 Jan;103:66-74. [View Abstract]External Web Site Policy

Enewold L, Sharon E, Harlan LC. Metastatic Melanoma: Treatment and Survival in the US after the Introduction of Ipilimumab and Vemurafenib. Oncol Res Treat. 2017;40(4):174-183. [View Abstract]External Web Site Policy

Parsons HM, Chu Q, Karlitz JJ, Stevens JL, Harlan LC. Adoption of Sorafenib for the Treatment of Advanced-Stage Hepatocellular Carcinoma in Oncology Practices in the United States. Liver Cancer. 2017 Jun;6(3):216-226. [View Abstract]External Web Site Policy

Coughlan D, Gianferante M, Lynch CF, Stevens JL, Harlan LC. Treatment and survival of childhood neuroblastoma: Evidence from a population-based study in the United States. Pediatr Hematol Oncol. 2017 Aug;34(5):320-330. [View Abstract]External Web Site Policy

Warren JL, Harlan LC, Trimble EL, Stevens J, Grimes M, Cronin KA. Trends in the receipt of guideline care and survival for women with ovarian cancer: A population-based study. Gynecol Oncol. 2017 Jun;145(3):486-492. [View Abstract]External Web Site Policy

2016

Harlan LC, Enewold L, Stevens JL. Early-stage breast cancer treatment in the US over 20 years: Changes in therapy and short-term cancer survival. Trends Cancer Res 2016;11:141-156.

Enewold L, Thomas A. Real-World Patterns of EGFR Testing and Treatment with Erlotinib for Non-Small Cell Lung Cancer in the United States. PLoS One. 2016 Jun 13;11(6):e0156728. eCollection 2016. [View Abstract]External Web Site Policy

Banegas MP, Harlan LC, Mann B, Yabroff KR. Toward greater adoption of minimally invasive and nephron-sparing surgical techniques for renal cell cancer in the United States. Urol Oncol. 2016 Oct;34(10):433.e9-433.e17. [View Abstract]External Web Site Policy

2015

Murphy CC, Harlan LC, Lund JL, Lynch CF, Geiger AM. Patterns of Colorectal Cancer Care in the United States: 1990-2010. J Natl Cancer Inst. 2015 Jul 23;107(10). pii: djv198. Print 2015 Oct. [View Abstract]External Web Site Policy

Murphy CC, Harlan LC, Warren JL, Geiger AM. Race and Insurance Differences in the Receipt of Adjuvant Chemotherapy Among Patients With Stage III Colon Cancer. J Clin Oncol. 2015 Aug 10;33(23):2530-6. [View Abstract]External Web Site Policy

Enewold L, Geiger AM, Zujewski J, Harlan LC. Oncotype Dx assay and breast cancer in the United States: usage and concordance with chemotherapy. Breast Cancer Res Treat. 2015 May;151(1):149-56. [View Abstract]External Web Site Policy

Harlan LC, Eisenstein J, Russell MC, Stevens JL, Cardona K. Gastrointestinal stromal tumors: treatment patterns of a population-based sample. J Surg Oncol. 2015 May;111(6):702-7. doi: 10.1002/jso.23879. [View Abstract]External Web Site Policy

Enewold L, Harlan LC, Tucker T, McKenzie S. Pancreatic cancer in the USA: persistence of undertreatment and poor outcome. J Gastrointest Cancer. 2015 Mar;46(1):9-20. doi: 10.1007/s12029-014-9668-x. [View Abstract]External Web Site Policy

Harlan LC, Parsons HM, Wiggins CL, Stevens JL, Patt YZ. Treatment of hepatocellular carcinoma in the community: disparities in standard therapy. Liver Cancer. 2015 Mar;4(1):70-83. doi: 10.1159/000367729. [View Abstract]External Web Site Policy

Warren JL, Butler EN, Stevens J, Lathan CS, Noone AM, Ward KC, Harlan LC. Receipt of chemotherapy among medicare patients with cancer by type of supplemental insurance. J Clin Oncol. 2015 Feb 1;33(4):312-8. [View Abstract]External Web Site Policy

Enewold L, Harlan LC, Stevens JL, Sharon E. Thyroid cancer presentation and treatment in the United States. Ann Surg Oncol. 2015;22(6):1789-97. [View Abstract]External Web Site Policy

2014

Banegas MP, Harlan LC, Mann B, Yabroff KR. Renal cell cancer: a shift in approaches for treatment of advanced disease in the United States. J Natl Compr Canc Netw. 2014 Sep;12(9):1271-9. [View Abstract]External Web Site Policy

Doria-Rose VP, Harlan LC, Stevens J, Little RF. Treatment of de novo acute myeloid leukemia in the United States: a report from the Patterns of Care program. Leuk Lymphoma. 2014 Nov;55(11):2549-55. [View Abstract]External Web Site Policy

Parsons HM, Harlan LC, Stevens JL, Ullmann CD. Treatment of small cell lung cancer in academic and community settings: factors associated with receiving standard therapy and survival. Cancer J. 2014 Mar-Apr;20(2):97-104. doi: 10.1097/PPO.0000000000000039. [View Abstract]External Web Site Policy

2013

Warren JL, Harlan LC, Stevens J, Little RF, Abel GA. Multiple myeloma treatment transformed: a population-based study of changes in initial management approaches in the United States. J Clin Oncol. 2013 Jun 1;31(16):1984-9. [View Abstract]External Web Site Policy

Butler EN, Chawla N, Lund J, Harlan LC, Warren JL, Yabroff KR. Patterns of colorectal cancer care in the United States and Canada: a systematic review. J Natl Cancer Inst Monogr. 2013;2013(46):13-35. Review. [View Abstract]External Web Site Policy

Lund JL, Stürmer T, Harlan LC, Sanoff HK, Sandler RS, Brookhart MA, Warren JL. Identifying specific chemotherapeutic agents in Medicare data: a validation study. Med Care. 2013 May;51(5):e27-34. doi: 10.1097/MLR.0b013e31823ab60f. [View Abstract]External Web Site Policy

Keegan TH, Moy LM, Foran JM, Alizadeh AA, Chang ET, Shema SJ, Schupp CW, Clarke CA, Glaser SL. Rituximab use and survival after diffuse large B-cell or follicular lymphoma: a population-based study. Leuk Lymphoma. 2013 Apr;54(4):743-51. [View Abstract]External Web Site Policy

2012

Dansky Ullmann C, Harlan LC, Shavers VL, Stevens JL. A population-based study of therapy and survival for patients with head and neck cancer treated in the community. Cancer. 2012 Sep 15;118(18):4452-61. [View Abstract]External Web Site Policy

Yabroff KR, Harlan L, Zeruto C, Abrams J, Mann B. Patterns of care and survival for patients with glioblastoma multiforme diagnosed during 2006. Neuro Oncol. 2012 Mar;14(3):351-9. [View Abstract]External Web Site Policy

2011

Parsons HM, Harlan LC, Seibel NL, Stevens JL, Keegan TH. Clinical trial participation and time to treatment among adolescents and young adults with cancer: does age at diagnosis or insurance make a difference? J Clin Oncol. 2011 Oct 20;29(30):4045-53. [View Abstract]External Web Site Policy

Harlan LC, Lynch CF, Ballard-Barbash R, Zeruto C. Trends in the treatment and survival for local and regional cutaneous melanoma in a US population-based study. Melanoma Res. 2011 Dec;21(6):547-54. doi: 10.1097/CMR.0b013e32834b58e4. [View Abstract]External Web Site Policy

Zujewski JA, Harlan LC, Morrell DM, Stevens JL. Ductal carcinoma in situ: trends in treatment over time in the US. Breast Cancer Res Treat. 2011 May;127(1):251-7. [View Abstract]External Web Site Policy

2010

Cronin KA, Harlan LC, Dodd KW, Abrams JS, Ballard-Barbash R. Population-based estimate of the prevalence of HER-2 positive breast cancer tumors for early stage patients in the US. Cancer Invest. 2010 Nov;28(9):963-8. doi: 10.3109/07357907.2010.496759. [View Abstract]External Web Site Policy

Harlan LC, Zujewski JA, Goodman MT, Stevens JL. Breast cancer in men in the United States: a population-based study of diagnosis, treatment, and survival. Cancer. 2010 Aug 1;116(15):3558-68. doi: 10.1002/cncr.25153. [View Abstract]External Web Site Policy

Wiggins CL, Harlan LC, Nelson HE, Stevens JL, Willman CL, Libby EN, Hromas RA. Age disparity in the dissemination of imatinib for treating chronic myeloid leukemia. Am J Med. 2010 Aug;123(8):764.e1-9. doi: 10.1016/j.amjmed.2010.03.018. [View Abstract]External Web Site Policy

Hamilton AS, Albertsen PC, Johnson TK, Hoffman R, Morrell D, Deapen D, Penson DF. Trends in the treatment of localized prostate cancer using supplemented cancer registry data. BJU Int. 2011 Feb;107(4):576-84. [View Abstract]External Web Site Policy

2009

Shavers VL, Harlan LC, Jackson M, Robinson J. Racial/ethnic patterns of care for pancreatic cancer. J Palliat Med. 2009 Jul;12(7):623-30. doi: 10.1089/jpm.2009.0036. [View Abstract]External Web Site Policy

Yabroff KR, Harlan L, Stevens J, Martin A. Patterns of care in adults with renal cell carcinoma: findings in a population based sample. J Urol. 2009 Jun;181(6):2462-8; discussion 2469. [View Abstract]External Web Site Policy

Gadgeel SM, Harlan LC, Zeruto CA, Osswald M, Schwartz AG. Patterns of care in a population-based sample of soft tissue sarcoma patients in the United States. Cancer. 2009 Jun 15;115(12):2744-54. doi: 10.1002/cncr.24307. [View Abstract]External Web Site Policy

Osswald M, Harlan LC, Penson D, Stevens JL, Clegg LX. Treatment of a population based sample of men diagnosed with testicular cancer in the United States. Urol Oncol. 2009 Nov-Dec;27(6):604-10. [View Abstract]External Web Site Policy

2008

Trimble EL, Harlan LC, Gius D, Stevens J, Schwartz SM. Patterns of care for women with cervical cancer in the United States. Cancer. 2008 Aug 15;113(4):743-9. doi: 10.1002/cncr.23682. [View Abstract]External Web Site Policy

Huang GJ, Hamilton AS, Lo M, Stein JP, Penson DF. Predictors of intravesical therapy for nonmuscle invasive bladder cancer: results from the surveillance, epidemiology and end results program 2003 patterns of care project. J Urol. 2008 Aug;180(2):520-4; discussion 524. [View Abstract]External Web Site Policy

Cronin-Fenton DP, Mooney MM, Clegg LX, Harlan LC. Treatment and survival in a population-based sample of patients diagnosed with gastroesophageal adenocarcinoma. World J Gastroenterol. 2008 May 28;14(20):3165-73. [View Abstract]External Web Site Policy

Stroup AM, Harlan LC, Trimble EL. Demographic, clinical, and treatment trends among women diagnosed with vulvar cancer in the United States. Gynecol Oncol. 2008 Mar;108(3):577-83. [View Abstract]External Web Site Policy

Yabroff KR, Harlan LC, Clegg LX, Ballard-Barbash R, Stevens J, Weaver DL. Is mode of breast cancer detection associated with cancer treatment in the United States? Cancer. 2008 Mar 1;112(5):1011-9. doi: 10.1002/cncr.23260. [View Abstract]External Web Site Policy

2006

Cronin DP, Harlan LC, Potosky AL, Clegg LX, Stevens JL, Mooney MM. Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer. Am J Gastroenterol. 2006 Oct;101(10):2308-18. [View Abstract]External Web Site Policy

Mariotto AB, Feuer EJ, Harlan LC, Abrams J. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999. J Natl Cancer Inst Monogr. 2006;(36):7-15. [View Abstract]External Web Site Policy

Klabunde CN, Harlan LC, Warren JL. Data sources for measuring comorbidity: a comparison of hospital records and medicare claims for cancer patients. Med Care. 2006 Oct;44(10):921-8. [View Abstract]External Web Site Policy

Harlan LC, Clegg LX, Abrams J, Stevens JL, Ballard-Barbash R. Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000. J Clin Oncol. 2006 Feb 20;24(6):872-7. [View Abstract]External Web Site Policy

2005

Warren JL, Weaver DL, Bocklage T, Key CR, Platz CE, Cronin KA, Ballard-Barbash R, Willey SC, Harlan LC. The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis. Cancer. 2005 Nov 1;104(9):1840-8. [View Abstract]External Web Site Policy

Harlan LC, Greene AL, Clegg LX, Mooney M, Stevens JL, Brown ML. Insurance status and the use of guideline therapy in the treatment of selected cancers. J Clin Oncol. 2005 Dec 20;23(36):9079-88. [View Abstract]External Web Site Policy

Cronin DP, Harlan LC, Clegg LX, Stevens JL, Yuan G, Davis TA. Patterns of care in a population-based random sample of patients diagnosed with non-Hodgkin's lymphoma. Hematol Oncol. 2005 Jun;23(2):73-81. [View Abstract]External Web Site Policy

Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, Schrag D, Jamison PM, Jemal A, Wu XC, Friedman C, Harlan L, Warren J, Anderson RN, Pickle LW. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst. 2005 Oct 5;97(19):1407-27. [View Abstract]External Web Site Policy

Trimble EL, Harlan LC, Clegg LX, Stevens JL. Pre-operative imaging, surgery and adjuvant therapy for women diagnosed with cancer of the corpus uteri in community practice in the United States. Gynecol Oncol. 2005 Mar;96(3):741-8. [View Abstract]External Web Site Policy

2004

Potosky AL, Saxman S, Wallace RB, Lynch CF. Population variations in the initial treatment of non-small-cell lung cancer. J Clin Oncol. 2004 Aug 15;22(16):3261-8. [View Abstract]External Web Site Policy

2003

Shavers VL, Harlan LC, Stevens JL. Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer. 2003 Jan 1;97(1):134-47. [View Abstract]External Web Site Policy

Harlan LC, Clegg LX, Trimble EL. Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States. J Clin Oncol. 2003 Sep 15;21(18):3488-94. [View Abstract]External Web Site Policy

Shavers VL, Harlan LC, Winn D, Davis WW. Racial/ethnic patterns of care for cancers of the oral cavity, pharynx, larynx, sinuses, and salivary glands. Cancer Metastasis Rev. 2003 Mar;22(1):25-38. [View Abstract]External Web Site Policy

Snyder C, Harlan L, Knopf K, Potosky A, Kaplan R. Patterns of care for the treatment of bladder cancer. J Urol. 2003 May;169(5):1697-701. [View Abstract]External Web Site Policy

2002

Warren JL, Harlan LC, Fahey A, Virnig BA, Freeman JL, Klabunde CN, Cooper GS, Knopf KB. Utility of the SEER-Medicare data to identify chemotherapy use. Med Care. 2002 Aug;40(8 Suppl):IV-55-61. [View Abstract]External Web Site Policy

Harlan LC, Abrams J, Warren J, Clegg L, Stevens J, Ballard-Barbash R. Adjuvant therapy for breast cancer: practice patterns of community physicians J Clin Oncol. 2002 Apr;20:1809-17. [View Abstract]External Web Site Policy

Mariotto A, Feuer EJ, Harlan LC, Wun LM, Johnson KA, Abrams J. Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999. J Natl Cancer Inst. 2002 Nov 6;94(21):1626-34. [View Abstract]External Web Site Policy

Potosky AL, Harlan LC, Kaplan RS, Johnson KA, Lynch CF. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol. 2002 Mar 1;20(5):1192-202. [View Abstract]External Web Site Policy

1997

Muñoz KA, Harlan LC, Trimble EL. Patterns of care for women with ovarian cancer in the United States. J Clin Oncol. 1997 Nov;15(11):3408-15. [View Abstract]External Web Site Policy

Last Updated: 25 Feb, 2020